Your browser doesn't support javascript.
loading
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP).
Banach, Maciej; Penson, Peter E; Vrablik, Michal; Bunc, Matjaz; Dyrbus, Krzysztof; Fedacko, Jan; Gaita, Dan; Gierlotka, Marek; Jarai, Zoltan; Magda, Stefania Lucia; Margetic, Eduard; Margoczy, Roman; Durak-Nalbantic, Azra; Ostadal, Petr; Pella, Daniel; Trbusic, Matias; Udroiu, Cristian Alexandru; Vlachopoulos, Charalambos; Vulic, Dusko; Fras, Zlatko; Dudek, Dariusz; Reiner, Zeljko.
Afiliação
  • Banach M; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Department of Hypertension, Medical University of Lodz (MUL), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland. Electronic address: maciej.banach@iczmp.edu.pl.
  • Penson PE; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK; Liverpool Centre for Cardiovascular Science, Liverpool, UK.
  • Vrablik M; 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Bunc M; Department of Cardiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Dyrbus K; 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Fedacko J; MEDIPARK, University Research Park for Preclinical and Clinical Research, Pavol Jozef Safarik University, Kosice, Slovakia.
  • Gaita D; Institute of Cardiovascular Diseases, University of Medicine and Pharmacy Victor Babes, Timisoara, Romania.
  • Gierlotka M; Department of Cardiology, University Hospital in Opole, Institute of Medical Sciences, University of Opole, Opole, Poland.
  • Jarai Z; Department of Cardiology, Saint Imre University Teaching Hospital, Budapest, Hungary.
  • Magda SL; University of Medicine and Pharmacy "Carol Davila" and University and Emergency Hospital, Department of Cardiology and Cardiovascular Surgery, Bucharest, Romania.
  • Margetic E; Clinic of Cardiovascular Diseases, University Hospital Center Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia.
  • Margoczy R; Middle Slovak Institute of Cardiovascular Diseases, Banska Bystrica, Slovakia.
  • Durak-Nalbantic A; Department for Cardiology, Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Ostadal P; Cardiovascular Center, Na Homolce Hospital, Prague, Czech Republic.
  • Pella D; 2nd Department of Cardiology Clinic of PJ Safarik University and East Slovak Institute for Cardiovascular Diseases, Kosice, Slovakia.
  • Trbusic M; Department of Cardiology, Sestre Milosrdnice University Hospital Center, School of Medicine University of Zagreb, Zagreb, Croatia.
  • Udroiu CA; University of Medicine and Pharmacy "Carol Davila" and University and Emergency Hospital, Department of Cardiology and Cardiovascular Surgery, Bucharest, Romania.
  • Vlachopoulos C; First Cardiology Department, Hippokration Hospital, Athens Medical School, National and Kapodistrian University of Athens, Greece.
  • Vulic D; Faculty of Medicine, University of Banja Luka, Bosnia and Herzegovina.
  • Fras Z; Preventive Cardiology Unit, Department of Vascular Medicine, Division of Medicine, University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Dudek D; Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Ravenna, Italy.
  • Reiner Z; Department of Internal Medicine, University Hospital Center Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia. Electronic address: zeljko.reiner@kbc-zagreb.hr.
Pharmacol Res ; 166: 105499, 2021 04.
Article em En | MEDLINE | ID: mdl-33607265
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aterosclerose / Síndrome Coronariana Aguda / Ezetimiba / Inibidores de PCSK9 / Anticolesterolemiantes Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aterosclerose / Síndrome Coronariana Aguda / Ezetimiba / Inibidores de PCSK9 / Anticolesterolemiantes Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article